A randomised, double-blind, placebo-controlled trial to investigate the safety and pharmacokinetics of Ulipristal acetate in healthy women.
Phase of Trial: Phase I
Latest Information Update: 03 Dec 2015
At a glance
- Drugs Ulipristal (Primary)
- Indications Uterine leiomyoma
- Focus Adverse reactions; Pharmacodynamics
- 03 Dec 2015 New trial record